584 — AJJ Medtech Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- SG$3.01m
- SG$5.30m
- SG$2.32m
Annual cashflow statement for AJJ Medtech Holdings, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.79 | -1.74 | -4.52 | -2.56 | -3.87 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.5 | -2.18 | 0.383 | -0.025 | 0.716 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.596 | -2.23 | 0.203 | 0.403 | 1.13 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.761 | -5.54 | -3.2 | -1.74 | -1.61 |
| Capital Expenditures | -0.411 | -0.5 | -0.035 | -0.003 | -0.009 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.405 | 9.49 | 0 | 0.374 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.816 | 8.99 | -0.035 | 0.371 | -0.009 |
| Financing Cash Flow Items | — | — | — | -0.045 | -0.154 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.19 | -0.402 | -0.255 | 1.61 | 1.22 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.616 | 3.05 | -3.5 | 0.239 | -0.401 |